Finished dosage products
Finished dosage products are manufactured in Budapest and at three foreign production sites. Around 65% of our finished dosage products are manufactured in Budapest, 16% in Russia, 12% in Romania and 8% in Poland.
In five plants employing 1000 people, we produce more than 2000 preparations.
Gel and ointment at the Galenus plant, solid dosage forms at the Tablet and Packaging plant, and parenteral preparations at our Injection manufacturing and Injection packaging plants. Ointments are produced in the millions, batches of injections in the hundreds, and tablets and capsules in the billions. The in-house manufactured, solid dosage forms of our Women's Healthcare strategic pillar are all produced in Budapest, steroid production and packaging capacities are only available here.
Gedeon Richter RUS
Gedeon Richter's products have always been very popular on the Russian market because of their reliability, effectiveness and affordability. Therefore, in 1996 the decision was made to set up a manufacturing unit in the town of Yegoryevsk near Moscow.
Gedeon Richter RUS is engaged in the manufacturing of finished dosage drugs and solid form packaging (tablet, capsule). Its products cover several therapeutic areas. Among these are antiallergic, cardiovascular, antiulcer, anti-inflammatory, tranquillizer and antibacterial preparations. Its major markets are the CIS countries and Hungary.
The company employs about 400 employees and this number is constantly increasing due to the company's development.
The Russian manufacturing site operates according to GMP and ISO regulations.
Gedeon Richter Romania
The history of the Tirgu Mures-based Gedeon Richter Romania goes back to 1985, when the foundation stone of the pharmaceutical plant Armedica was laid. Manufacturing began four years later. It was in 1998 that Richter purchased a 50.98% majority stake in Armedica from the Romanian state.
Thanks to the continuous facility developments (setting up a regional development laboratory and a logistics centre, development of the tabletting, ointment and finished dosage plants, and modernisation of the service units), the modern preparations produced by the Romanian subsidiary comply with regulations and the company has undergone several successful Romanian and international GMP inspections.
Gedeon Richter Polska
A major chemical company in Poland prior to World War II, Grodziskie Zaklady Farmaceutyczne commenced operations in 1885. The company joined the Richter Group in 2002 when Gedeon Richter acquired a 51% majority stake.
Since then Richter’s ownership in the company increased to 99.8% and major capital expenditure programmes have been concluded including a state-of-the-art the finished dosage product plant, a pilot plant and a warehouse.
With a headcount of 740 employees, Gedeon Richter Polska is engaged in the manufacturing of finished dosage drugs and solid form packaging (tablet, capsule). The product portfolio comprises gastrointestinal, cardiovascular and anti-inflammatory preparations. Polfa markets 32 brands in several presentations in Poland. Its major export markets are Russia, Belarus, Uzbekistan, Romania and the Ukraine.
Similar to the parent company, GR Polska is also involved in marketing, promotion and R&D as well.